Clinical efficacy of linezolid in the treatment of tuberculous meningitis: a retrospective analysis and literature review
Highlights Retrospective study evaluating linezolid in 99 TBM patients. Linezolid significantly reduced CSF protein levels, especially in critically ill patients. Similar adverse event rates between groups. Relevant literature reviews were reviewed.
Saved in:
| Main Authors: | Zhen-Tao Fei, Wei Huang, Dan-Ping Zhou, Yang Yang, Ping Liu, Ning Gan, Ping-Ping He, Dan Ye, Hua-Rui Liu, Xu-Hui Liu, Lu Xia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Infectious Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12879-025-10874-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tuberculous meningitis initially presented with low levels of pleocytosis and protein in the cerebrospinal fluid: a case report
by: Hyung-Kyum Kim, et al.
Published: (2025-07-01) -
Normal cerebrospinal fluid protein and associated clinical characteristics in children with tuberculous meningitis
by: Jun-Li Wang, et al.
Published: (2021-01-01) -
Single‐Cell Metabolic Labeling Probe for Diagnosing Tuberculous Meningitis: A Case Report
by: Jiahao Wang, et al.
Published: (2025-06-01) -
Predictors of cerebrospinal fluid GeneXpert MTB/RIF positivity in patients with tuberculous meningitis: A prospective cohort study
by: Priyanka Gupta, et al.
Published: (2024-10-01) -
Performance of Xpert MTB/RIF ultra for the diagnosis of tuberculous meningitis in children using cerebrospinal fluid
by: S. M. Mazidur Rahman, et al.
Published: (2025-04-01)